SCHEMBL18238951

SCHEMBL18238951

CCc1cc2ncoc2cn1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
LMNA P02545 1/20 0.35
TRPM5 Q9NZQ8 1/20 0.35
DYRK1A Q13627 2/20 0.34
CTNNB1 P35222 3/20 0.33
WNT3A P56704 3/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNA4 P43681 1/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
ESR1 P03372 1/20 0.32
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25724458 0.85 LMNA (0.36) MEN1ALDH1A1GAAKMT2ALMNA
SCHEMBL20631795 0.85 LMNA (0.38) MEN1ALDH1A1GAAKMT2ALMNA
SCHEMBL26754608 0.80 NOS3 (0.37) MEN1ALDH1A1GAAKMT2ALMNA
SCHEMBL13558508 0.74 DYRK1A (0.37) MEN1ALDH1A1GAAKMT2ALMNA
SCHEMBL13311450 0.72 MEN1 (0.42) MEN1ALDH1A1GAAKMT2ALMNA
SCHEMBL13557976 0.71 DYRK1A (0.35) MEN1ALDH1A1GAAKMT2ATRPM5
SCHEMBL20631803 0.69 MEN1 (0.40) MEN1ALDH1A1GAAKMT2ALMNA
SCHEMBL26750295 0.69 DYRK1A (0.34) MEN1ALDH1A1GAAKMT2ATRPM5
SCHEMBL2620971 0.69 MEN1 (0.60) MEN1ALDH1A1GAAKMT2ALMNA
SCHEMBL941915 0.69 CHRNB2 (0.48) MEN1ALDH1A1GAAKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081637-A1 FUSED TETRACYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2 ENLIVEN THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed
EP-3838897-A2 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen TargetRx, Inc. (CN) 2021-06-23 EP disclosed
EP-3553056-B1 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY SHENZHEN TARGETRX INC (CN) 2021-02-17 EP disclosed
EP-3553056-A1 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen Targetrx, Inc. (CN) 2019-10-16 EP disclosed
WO-2016183359-A1 SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME BLINKBIO, INC. (US) 2016-11-17 WO disclosed